Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma.

J Immunother Cancer · 2019 · PMC6585080 · PMID 31221219

Europe PMC DOI

hedged sentence

0.0596

closest p · 1.2× alpha

0.0596

boldest claim

The sentences

showed a trendP = 0.0596so close (0.05 < p ≤ 0.1)

Comparisons of IRF8 scores with survival data showed a trend towards improved progression-free survival with high levels of IRF8 expression that did not reach significance ( P = 0.0596, Fig. 2 c).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.